Posted in Big Pharma, consumer interest on June 11, 2008 | No Comments »
Dr. Carlat at it again. Here’s his take on Continuing Medical Education. It’s been said many times, but this is so to the point:
As I described last year in thei New York Times op-ed, much of the continuing medical education (CME) industry in the United States is a legalized money laundering operation. Rather than paying [...]
Posted in Big Pharma, compliance professionals, medical model, prescription privileges, what psychologists do on June 5, 2008 | No Comments »
One from the archives, July 2007.
This is the first entry in a series on the implications of psychologists pursuing prescription privileges. What those implications are exactly, is far from clear — they ought to be examined very closely. Others in the series include:
Prescription Privileges for Psychologists: An Intro to “Pro” Arguments
Presciptive Authority: Strong Arguments
Here’s a [...]
Posted in Big Pharma, psychology in the media on May 14, 2008 | No Comments »
Found a whole slew of articles on disease mongering from a link at the Icarus Project’s articles and writing section. Monger: To stir up or spread. Some article titles:
Bigger and Better: How Pfizer Redefined Erectile Dysfunction
Medicine Goes to School: Teachers as Sickness Brokers for ADHD
Pharmaceutical Marketing and the Invention of the Medical Consumer
Female Sexual Dysfunction: [...]
Posted in Big Pharma, psychotropic drugs on May 9, 2008 | No Comments »
Everyone Needs Therapy (April 6) has an interesting post commenting on a Wall Street Journal article on, you guessed it, sleeping pills. Not surprisingly, they can have some unintended effects. Since the usual suspects here are SSRIs and atypical antipsychotics — here’s a look at sleeping pills. More fun from Big Pharma.
Kalea Chapman, Psy.D.
Posted in Big Pharma, Freud, PTSD, brain and behavior, cognitive-behavior therapy, human problems, medical model, neuroscience, psychiatry, psychoanalysis, psychology in the media, psychotherapy, psychotropic drugs, science and psychology on May 8, 2008 | No Comments »
From Biological Psychiatry to Aplysia californica. Recently read Charles Barber’s Comfortably Numb: How Psychiatry is Medicating a Nation, a book noted elsewhere on this blog. It’s a compelling read that covers a lot of ground — the rise of Big Pharma and what he calls “The Triumph of Biological Psychiatry” (a history of how psychiatry [...]
Posted in Big Pharma, bipolar disorder, blogging, consumer interest, depression, manic depression, psychology in the media, psychotropic drugs on May 7, 2008 | 2 Comments »
Two indicators: Research and practice. Well a new study seems to indicate that overdiagnosis is the order of the day. Furious Seasons has two stories on this topic, April 6 and 7, both quotes are straight from Furious Seasons.
Clinical Psychology and Psychiatry, advocating a Bipolar Overawareness Week, has an extensive treatment of the topic, with [...]
Posted in Big Pharma, consumer interest, diagnosis, medical model, psychotropic drugs on May 7, 2008 | No Comments »
No surprises here. The Diagnostic Statistical Manual (DSM) used to diagnose “mental illness” is linked to the psychopharm industry. From the New York Times, here:
More than half of the task force members who will oversee the next edition of the American Psychiatric Association’s most important diagnostic handbook have ties to the drug industry, reports a [...]
Posted in Big Pharma on May 2, 2008 | No Comments »
Furious Seasons addresses an important and often overlooked topic. What happens when people want to get off their meds after years of use?
So we’re clear on where I’m coming from, I am not arguing that anyone should or shouldn’t be off-meds. That choice belongs to patients almost exclusively, or it should. What I am saying [...]
Posted in Big Pharma, consumer interest, psychology in the media, psychotropic drugs, public interest on May 1, 2008 | No Comments »
If this trend continues, it promises to be good news:
Drug and medical device companies should be banned from offering free food, gifts, travel and ghost-writing services to doctors, staff and students in all 129 of the nation’s medical colleges, an influential college association has concluded….
Drug companies spend billions of dollars wooing doctors — more than [...]
Posted in Big Pharma, consumer interest, persuasion, psychology in the media, psychotherapy on May 1, 2008 | No Comments »
Art of promotion. From PsychCentral, the discrepancy between promoting drugs and promoting good talk therapy:
This is a problem I’ve long noted — that every time a drug gets released or new research is published about it, the drug company makes sure you and everyone else knows about it. Through press releases, news brief, and numerous [...]
pasadena therapist